Need for infliximab dose intensification in Crohn’s disease and ulcerative colitis

Table 4 Summary of studies of infliximab dose intensification in ulcerative colitis: Proportion of patients who needed infliximab intensification

Ref.	Patients1	Median duration of follow-up (mo)	Dose intensification
Rostholder et al[7]	50	142	54%
Oussalah et al[8]	80	18	45%
Seow et al[9]	93	14	58%
Arias et al[10]	136	14	46%
Present study	38	9	42%

¹Only patients who responded and started maintenance therapy;

²Mean duration.